Trial: Imiquimod cream treats sun-related skin lesion
Researchers at Mount Sinai Medical Center in New York found that 46.7% of people with actinic keratosis -- a form of skin lesion caused by long-term sun exposure -- reported improvement in affected areas after 24 weeks of treatment with imiquimod, a prescription cream. The 20-patient study also noted that adverse reactions such as mild skin redness were minimal to nonexistent.
Yahoo! | 01/12
This story published in FMI Pharmacy dailyLead on 01/13/2009
More from SmartBrief:
Mediterranean diet, exercise might protect against Alzheimer's
Thursday, August 13, 2009
N.Y. halts mandatory flu shots for health workers
Friday, October 23, 2009
Walgreen adds home health care to its services
Thursday, August 6, 2009
Get stories like these delivered daily for FREE:
|
FMI Pharmacy dailyLead
Designed specifically for pharmacy professionals, FMI Pharmacy dailyLead is a FREE, daily e-mail newsletter. It provides the latest news in the pharmacy arena. Learn more |
|